bioAffinity Technologies, Inc.
Nasdaq · Services-Commercial Physical & Biological Research · San Antonio, TX
BIAFW chart
What traders are saying about $BIAFW
Latest postsbioAffinity Technologies, Inc. news
- bioAffinity Technologies posts record monthly volume for CyPath Lung test
proactiveinvestors.com ·
- bioAffinity Technologies reports record CyPath Lung test volume in October
StreetInsider ·
- bioAffinity Technologies Reports Record Monthly Testing Volume in October for Its Noninvasive CyPath® Lung Test
Yahoo Finance ·
- A lung cancer test was performed 235 times in October, about 45% of the previous quarter’s total.
Stock Titan ·
- Weekly Recap: Going-concern doubt and CyPath Lung revenue growth
TradingView ·
- How Is CyPath Lung Commercialization Progressing at bioAffinity Technologies (NASDAQ:BIAF)?
Kalkine ·
- bioAffinity Technologies Posts $5.89 Q3 GAAP Loss Per Share
www.tokenpost.com ·
- bioAffinity Technologies, Inc. (BIAF) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- bioAffinity Technologies, Inc. (BIAF) stock price, news, quote and history
Yahoo Finance Singapore ·
- Form 8K bioAffinity Technologies Inc For: 6 November By Investing.com
Investing.com Australia ·
- bioAffinity Technologies earnings beat by $25.61, revenue fell short of estimates
Investing.com Nigeria ·
- bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization
Yahoo Finance ·
bioAffinity Technologies, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.2M | $9.4M | $2.5M | $4,803 |
| Net income | -$14.9M | -$9.0M | -$7.9M | -$8.2M |
| Diluted EPS | $-8.66 | $-22.50 | $-0.91 | $-1.81 |
| Total assets (year end) | $11.0M | $6.5M | $8.2M | $12.2M |
| Cash and equivalents (year end) | $6.4M | $1.1M | $2.8M | $11.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About bioAffinity Technologies, Inc.
- Ticker
- BIAFW (Nasdaq)
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- San Antonio, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1712762
- Former names
- bioAffinity Technologies, Inc.
Frequently asked questions
What exchange is bioAffinity Technologies, Inc. listed on?
bioAffinity Technologies, Inc. trades on the Nasdaq under the ticker symbol BIAFW.
What industry is bioAffinity Technologies, Inc. in?
bioAffinity Technologies, Inc. is classified by the SEC under "Services-Commercial Physical & Biological Research".
Where is bioAffinity Technologies, Inc. headquartered?
bioAffinity Technologies, Inc.'s business address on file with the SEC is in San Antonio, TX.
When does bioAffinity Technologies, Inc.'s fiscal year end?
bioAffinity Technologies, Inc.'s fiscal year ends on December 31.
How much revenue did bioAffinity Technologies, Inc. report?
bioAffinity Technologies, Inc. reported $6.2M in revenue for calendar year 2025, according to its SEC filings.